Colorless and transparent prefilled syringe containing clear or slightly opalescent liquid solution

2 kinds of subtype a and 2 kinds of subtype b of purified inactivated influenza virus surface antigen

• Prevention of influenza diseases caused by influenza A viruses and
• influenza B viruses contained in this vaccine for adults and children 6 months of age and older.

• 1. Administration schedule and dose
  • The following dose shall be injected intramuscularly, and the same dose shall be repeated once annually.
    • 1) Children 6 months of age and older and adults: inject 0.5 ml once.
    • 2) However, children under 9 years of age who have not been previously vaccinated against influenza shall be vaccinated with two doses at an interval of at least 4 weeks in the first year of vaccination.
• 2. Mode of administration
  • Inject intramuscularly at brachial deltoid muscle using a needle attached to the prefilled syringe.
  • For infants aged 6 months to 3 years, inject intramuscularly at the anterolateral thigh (or brachial deltoid muscle if muscle mass is sufficient).

0.5 ml/prefilled syringe x in-house package unit (1, 5, 10, 20)

Store at 2-8°c in an airtight container away from light without freezing.